Evidence map›Paper›PMID 33947668›Full record

Trial reportThe British journal of general practice : the journal of the Royal College of General Practitioners2021

Smoking cessation intervention in Australian general practice: a secondary analysis of a cluster randomised controlled trial.

Rukshar K Gobarani, Nicholas A Zwar, Grant Russell, Michael J Abramson, Billie Bonevski, Anne E Holland, Eldho Paul, Narelle S Cox, Sally Wilson, Johnson George

Open access · hybridAbstract readRandomized Controlled Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in The British journal of general practice : the journal of the Royal College of General Practitioners, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. Review
  3. Smoking Cessation Services by Community Pharmacists: Real-World Practice in Thailand.International journal of environmental research and public health · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Rukshar K GobaraniCentre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences.
Nicholas A ZwarFaculty of Health Sciences and Medicine, Bond University, Queensland, and School of Population Health, University of New South Wales, Sydney.
Grant RussellDepartment of General Practice, and director, Southern Academic Primary Care Research Unit, Department of General Practice.
Michael J AbramsonSchool of Public Health and Preventive Medicine.
Billie BonevskiCollege of Medicine and Public Health, Flinders University, Bedford Park, South Australia.
Anne E HollandDepartment of Allergy, Immunology and Respiratory Medicine, Monash University, Melbourne, and Department of Physiotherapy, Alfred Health, and Institute for Breathing and Sleep, Melbourne.
Eldho PaulSchool of Public Health and Preventive Medicine, Monash University, Melbourne.
Narelle S CoxDepartment of Allergy, Immunology and Respiratory Medicine, Monash University, and Institute for Breathing and Sleep, Melbourne.
Sally WilsonDepartment of Infrastructure Engineering, Faculty of Engineering and Information Technology, University of Melbourne, Melbourne.
Johnson GeorgeCentre for Medicine Use and Safety, Faculty of Pharmacy and Pharmaceutical Sciences.
Flinders University · AUMonash University · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGPs have limited capacity to routinely provide smoking cessation support. New strategies are needed to reach all smokers within this setting.

aimTo evaluate the effect of a pharmacist-coordinated interdisciplinary smoking cessation intervention delivered in Australian general practice. DESIGN AND

settingSecondary analysis of a cluster randomised controlled trial (RCT) conducted in 41 Australian general practices.

methodIn all, 690 current smokers were included in this study: 373 from intervention clinics (

resultsIntention-to-treat analysis showed similar CO-validated abstinence rates at 6 months in the intervention (4.0%) and control clinics (3.5%). No differences were observed in readiness-to-quit scores between groups at 6 months. CO-validated abstinence rates were similar in those who completed HMR and at least six sessions of HomeBase to those with COPD in usual care.

conclusionA pharmacist-coordinated interdisciplinary smoking cessation intervention when integrated in a general practice setting had no advantages over usual care. Further research is needed to evaluate the effect of HMR and home-based pulmonary rehabilitation on smoking abstinence in smokers with COPD.

Indexed as

General PracticeSmoking CessationAustraliaBehavior TherapyFamily PracticeHumansgeneral practicesmoking cessationtobacco use

Identifiers

PMID33947668
PMCPMC8103929
OpenAlexW3124299755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.